Previous close | 28.74 |
Open | 30.91 |
Bid | 31.13 x 51100 |
Ask | 31.55 x 25600 |
Day's range | 30.54 - 31.58 |
52-week range | 21.14 - 36.37 |
Volume | |
Avg. volume | 2,175,373 |
Market cap | 46.333B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 33.87 |
EPS (TTM) | 0.93 |
Earnings date | N/A |
Forward dividend & yield | 0.29 (0.92%) |
Ex-dividend date | 07 Feb 2024 |
1y target est | 33.30 |
ResMed Inc reports robust growth in revenue and earnings, alongside strategic discussions on market dynamics and future outlook.
While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.